Cargando…
Feasibility and Safety of Single-Probe Cryoablation with Liquid Nitrogen: An Initial Experience in 24 Various Tumor Lesions
SIMPLE SUMMARY: Percutaneous cryoablation was developed to minimally perform multi-organ tumor ablations. The most widely known cryotherapy systems use argon gas (high-pressure) and multiple needles to achieve sufficient ablations. The aim of our retrospective study was to assess the feasibility of...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655210/ https://www.ncbi.nlm.nih.gov/pubmed/36358850 http://dx.doi.org/10.3390/cancers14215432 |
_version_ | 1784829129440362496 |
---|---|
author | Kammoun, Tarek Prévot, Elodie Serrand, Chris Perolat, Romain de Forges, Hélène Houédé, Nadine Beregi, Jean-Paul Frandon, Julien |
author_facet | Kammoun, Tarek Prévot, Elodie Serrand, Chris Perolat, Romain de Forges, Hélène Houédé, Nadine Beregi, Jean-Paul Frandon, Julien |
author_sort | Kammoun, Tarek |
collection | PubMed |
description | SIMPLE SUMMARY: Percutaneous cryoablation was developed to minimally perform multi-organ tumor ablations. The most widely known cryotherapy systems use argon gas (high-pressure) and multiple needles to achieve sufficient ablations. The aim of our retrospective study was to assess the feasibility of a new cryotherapy system using single-probe liquid nitrogen for tumor lesions of various sizes and locations, and to evaluate the safety of cryoablation with this technique. Correlations between ice ball sizes and ablation zone sizes with two needle sizes (10G or 13G) and with the freezing duration were evaluated, as well as the sphericity of the ice ball and ablation zones. We showed that this technique is safe in all organs tested. We showed a correlation between the freezing duration and the ice ball size, but not with the ablation zone, which is useful for planning the procedure and treatment conducted by the oncology team. ABSTRACT: Background: Percutaneous cryoablation with liquid nitrogen is a new technique being used in the treatment of some malignant tumors. Our objective was to assess its feasibility in the ablation of tumor lesions of various sizes and locations. Methods: This retrospective, monocentric study included all consecutive patients who underwent percutaneous cryoablation with liquid nitrogen between December 2019 and March 2021. Cryoablation was performed using 10G or 13G cryoprobes. The ablation volume was measured on post-treatment CT or MRI. Results: 22 patients (24 lesions) were included, 16 of whom were men (73%), while median age was 66 years. The lesions were located in the bone (42%), kidney (29%), soft tissue (17%), lung (8%), or liver (4%). It was feasible in all tumor locations and produced median ablation zones 25 mm in width and 35 mm in length, with a 23 min median freezing time. Freezing duration was correlated with the ice volume (p Spearman = 0.02), but not with the ablation volume (p = 0.11). The average difference between the ablation zone and ice ball sizes were −6.4 mm in width and −7.7 mm in length. Both ice and ablation volumes were larger when using the 10G probe as compared to when the 13G was used. No complications were reported. Discussion: We showed that this technique was safe and feasible in all organs tested. The freezing duration was correlated with the ice ball size, but not with the ablation zone. |
format | Online Article Text |
id | pubmed-9655210 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96552102022-11-15 Feasibility and Safety of Single-Probe Cryoablation with Liquid Nitrogen: An Initial Experience in 24 Various Tumor Lesions Kammoun, Tarek Prévot, Elodie Serrand, Chris Perolat, Romain de Forges, Hélène Houédé, Nadine Beregi, Jean-Paul Frandon, Julien Cancers (Basel) Communication SIMPLE SUMMARY: Percutaneous cryoablation was developed to minimally perform multi-organ tumor ablations. The most widely known cryotherapy systems use argon gas (high-pressure) and multiple needles to achieve sufficient ablations. The aim of our retrospective study was to assess the feasibility of a new cryotherapy system using single-probe liquid nitrogen for tumor lesions of various sizes and locations, and to evaluate the safety of cryoablation with this technique. Correlations between ice ball sizes and ablation zone sizes with two needle sizes (10G or 13G) and with the freezing duration were evaluated, as well as the sphericity of the ice ball and ablation zones. We showed that this technique is safe in all organs tested. We showed a correlation between the freezing duration and the ice ball size, but not with the ablation zone, which is useful for planning the procedure and treatment conducted by the oncology team. ABSTRACT: Background: Percutaneous cryoablation with liquid nitrogen is a new technique being used in the treatment of some malignant tumors. Our objective was to assess its feasibility in the ablation of tumor lesions of various sizes and locations. Methods: This retrospective, monocentric study included all consecutive patients who underwent percutaneous cryoablation with liquid nitrogen between December 2019 and March 2021. Cryoablation was performed using 10G or 13G cryoprobes. The ablation volume was measured on post-treatment CT or MRI. Results: 22 patients (24 lesions) were included, 16 of whom were men (73%), while median age was 66 years. The lesions were located in the bone (42%), kidney (29%), soft tissue (17%), lung (8%), or liver (4%). It was feasible in all tumor locations and produced median ablation zones 25 mm in width and 35 mm in length, with a 23 min median freezing time. Freezing duration was correlated with the ice volume (p Spearman = 0.02), but not with the ablation volume (p = 0.11). The average difference between the ablation zone and ice ball sizes were −6.4 mm in width and −7.7 mm in length. Both ice and ablation volumes were larger when using the 10G probe as compared to when the 13G was used. No complications were reported. Discussion: We showed that this technique was safe and feasible in all organs tested. The freezing duration was correlated with the ice ball size, but not with the ablation zone. MDPI 2022-11-04 /pmc/articles/PMC9655210/ /pubmed/36358850 http://dx.doi.org/10.3390/cancers14215432 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Kammoun, Tarek Prévot, Elodie Serrand, Chris Perolat, Romain de Forges, Hélène Houédé, Nadine Beregi, Jean-Paul Frandon, Julien Feasibility and Safety of Single-Probe Cryoablation with Liquid Nitrogen: An Initial Experience in 24 Various Tumor Lesions |
title | Feasibility and Safety of Single-Probe Cryoablation with Liquid Nitrogen: An Initial Experience in 24 Various Tumor Lesions |
title_full | Feasibility and Safety of Single-Probe Cryoablation with Liquid Nitrogen: An Initial Experience in 24 Various Tumor Lesions |
title_fullStr | Feasibility and Safety of Single-Probe Cryoablation with Liquid Nitrogen: An Initial Experience in 24 Various Tumor Lesions |
title_full_unstemmed | Feasibility and Safety of Single-Probe Cryoablation with Liquid Nitrogen: An Initial Experience in 24 Various Tumor Lesions |
title_short | Feasibility and Safety of Single-Probe Cryoablation with Liquid Nitrogen: An Initial Experience in 24 Various Tumor Lesions |
title_sort | feasibility and safety of single-probe cryoablation with liquid nitrogen: an initial experience in 24 various tumor lesions |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655210/ https://www.ncbi.nlm.nih.gov/pubmed/36358850 http://dx.doi.org/10.3390/cancers14215432 |
work_keys_str_mv | AT kammountarek feasibilityandsafetyofsingleprobecryoablationwithliquidnitrogenaninitialexperiencein24varioustumorlesions AT prevotelodie feasibilityandsafetyofsingleprobecryoablationwithliquidnitrogenaninitialexperiencein24varioustumorlesions AT serrandchris feasibilityandsafetyofsingleprobecryoablationwithliquidnitrogenaninitialexperiencein24varioustumorlesions AT perolatromain feasibilityandsafetyofsingleprobecryoablationwithliquidnitrogenaninitialexperiencein24varioustumorlesions AT deforgeshelene feasibilityandsafetyofsingleprobecryoablationwithliquidnitrogenaninitialexperiencein24varioustumorlesions AT houedenadine feasibilityandsafetyofsingleprobecryoablationwithliquidnitrogenaninitialexperiencein24varioustumorlesions AT beregijeanpaul feasibilityandsafetyofsingleprobecryoablationwithliquidnitrogenaninitialexperiencein24varioustumorlesions AT frandonjulien feasibilityandsafetyofsingleprobecryoablationwithliquidnitrogenaninitialexperiencein24varioustumorlesions |